Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Biontech, Chugai, Direct Biologics, Genentech, HDT, Hutchmed, Ildong, Innocare, Innovent, Junshi, Lupin, Moderna, Pfizer, Roche, Solasia, Yiling.